0000874716-24-000015.txt : 20240209 0000874716-24-000015.hdr.sgml : 20240209 20240209170155 ACCESSION NUMBER: 0000874716-24-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240207 FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCKEON BRIAN P CENTRAL INDEX KEY: 0001219445 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 24615950 MAIL ADDRESS: STREET 1: IDEXX LABORATORIES STREET 2: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 wk-form4_1707516080.xml FORM 4 X0508 4 2024-02-07 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001219445 MCKEON BRIAN P ONE IDEXX DRIVE WESTBROOK ME 04092 0 1 0 0 EVP, CFO and Treasurer 0 Common Stock 2024-02-07 4 M 0 23326 141.60 A 53043.5926 D Common Stock 2024-02-07 4 S 0 615 563.8158 D 52428.5926 D Common Stock 2024-02-07 4 S 0 1581 564.976 D 50847.5926 D Common Stock 2024-02-07 4 S 0 701 566.533 D 50146.5926 D Common Stock 2024-02-07 4 S 0 1564 567.3487 D 48582.5926 D Common Stock 2024-02-07 4 S 0 1469 568.8449 D 47113.5926 D Common Stock 2024-02-07 4 S 0 3912 569.9132 D 43201.5926 D Common Stock 2024-02-07 4 S 0 5675 570.9697 D 37526.5926 D Common Stock 2024-02-07 4 S 0 7128 571.8381 D 30398.5926 D Common Stock 2024-02-07 4 S 0 681 572.8041 D 29717.5926 D Common Stock 18050 I by Estony McKeon Family, LLC Non-Qualified Stock Option (right-to-buy) 141.60 2024-02-07 4 M 0 23326 D 2027-02-13 Common Stock 23326 0 D Includes a total of 25.247 shares purchased under the Issuer Employee Stock Purchase Plan on September 29, 2023 and December 29, 2023. Represents the weighted average price of the shares sold ranging from a low of $563.48 to a high of $564.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $564.63 to a high of $565.50 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $565.89 to a high of $566.84 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $566.92 to a high of $567.86 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $568.33 to a high of $569.28 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $569.34 to a high of $570.34 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $570.345 to a high of $571.34 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $571.36 to a high of $572.33 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $572.42 to a high of $573.09 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Grant of option to buy shares of Issuer common stock that vested in five annual installments beginning February 14, 2018. Not applicable. /s/ Lily J. Lu, Attorney-in-Fact for Brian P. McKeon 2024-02-09